Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment

Radiation Research

Volumn 178, Issue 1, 2012, Pages 45-56

  Lee, Tammy C ^a   Greene Schloesser, Dana ^a   Payne, Valerie ^a   Diz, Debra I ^a   Hsu, Fang Chi ^a   Kooshki, Mitra ^a   Mustafa, Rashida ^a   Riddle, David R ^a   Zhao, Weiling ^a   Chan, Michael D ^a   Robbins, Mike E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAMIPRIL; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN RADIATION; CELL ACTIVATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; FRACTIONATED WHOLE BRAIN IRRADIATION; MALE; MICROGLIA; NONHUMAN; PERIRHINAL CORTEX DEPENDENT COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RAT; RECOGNITION; SHAM PROCEDURE; TASK PERFORMANCE; ANIMAL; BLOOD; BODY WEIGHT; BRAIN CORTEX; FISCHER 344 RAT; PHYSIOLOGY; RADIATION EXPOSURE; SKULL IRRADIATION;

RATTUS;

ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CEREBRAL CORTEX; COGNITION DISORDERS; CRANIAL IRRADIATION; DOSE FRACTIONATION; MALE; RADIATION INJURIES, EXPERIMENTAL; RAMIPRIL; RATS; RATS, INBRED F344;

EID: 84864445722     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2731.1     Document Type: Article

References (68)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer Statistics, 2011. Ca Cancer J Clin 2011; 61:212-36.
2. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003; 29:533-40.
3. Khuntia D, Brown P, Li J, Mehta MP. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006; 24:1295-304.
4. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiationinduced encephalopathy. J Clin Oncol 1994; 12: 627-42.
5. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 2006; 24:1305-9.
6. Shaw EG, Rosdahl R, D'Agostino RB, Lovato J, Naughton MJ, Robbins ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006; 24:1415-20.
7. Murray EA, Bussey TJ, Saksida LM. Visual perception and memory: a new view of medial temporal lobe function in primates and rodents. Annu Rev Neurosci 2007; 30:99-122.
8. Brown WR, Blair RM, Moody DM, Robbins ME, Wheeler KT. Capillary loss precedes the cognitive impairment induced by fractionated whole-brain irradiation: A potential rat model of vascular dementia. J Neurol Sci 2007; 257:67-71.
9. Raber R, Rola R, LeFevour A, Morhardt D, Curley J, Mizumatsu S, et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res 2004; 162:39-47.
10. Atwood T, Payne VS, Zhao W, Brown WR, Wheeler KT, Zhu JM, et al. Quantitative magnetic resonance spectroscopy reveals a potential relationship between radiation-induced changes in rat brain metabolites and cognitive impairment. Radiat Res 2007; 168:574-81.
11. Monje M. Cranial radiation therapy and damage to hippocampal neurogenesis. Devel Disabil Res Rev 2008; 14:238-42.
12. Barani IJ, Benedict SH, Lin P-S. Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys 2007; 68:324-33.
13. Monje ML, Mizumatsu S, Fike JR, Palmer T. Irradiation induced neural precursor-cell dysfunction. Nat Med 2002; 8:955-61.
14. Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike Jr. Extreme sensitivity of adult neurogenesis to low doses of Xirradiation. Cancer Res 2003; 63:4021-7.
15. Vallières L, Campbell IL, Gage FH, Sawchenko PE. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astroctyic production of interleukin-6. J Neurosci 2002; 22:486-92.
16. Ekdahl CT, Kokaia Z, Lindvall G. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009; 158:1021-9.
17. Mildenberger M, Beach TG, McGeer EG, Ludgate CM. An animal model of prophylactic cranial irradiation: histologic effects at acute, early and delayed stages. Int J Radiat Oncol Biol Phys 1990; 18:1051-60.
18. Robbins ME, Zhao W, Garcia-Espinosa MA, Diz DI. Renin-Angiotensin system blockers and modulation of radiation-induced brain injury. Curr Drug Targets 2010; 11:1413-22.
19. Kim JH, Brown SL, Kolozsvary A, Jenrow KA, Ryu S, Rosenblum ML, et al. Modification of radiation injury by ramipril, inhibitor of Angiotensin- converting enzyme, on optic neuropathy in the rat. Radiat Res 2004; 161:137-42.
20. Robbins ME, Payne V, Tommasi E, Diz DI, Hsu F-C, Brown WR, et al. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 2009; 73:499-505.
21. Saavedra JM. Brain Angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 2005; 25:485-511.
22. Benicky J, Sanchez-lemus E, Pavel J, Saavedra JM. Antiinflammatory effects of angiotensin receptor blockers in the brain and periphery. Cell Mol Neurobiol 2009; 29:781-92.
23. Brown WR, Thore CR, Moody DM, Robbins ME, Wheeler KT. Vascular damage after fractionated whole-brain irradiation in rats. Radiat Res 2005; 164:662-8.
24. Fowler JF. Brief summary of radiobiological principles in fractionated radiotherapy. Semin Radiat Oncol 1992; 2:16-21.
25. van der Kogel AJ. The nervous system: Radiobiology and experimental pathology. In: Schrer E, Streffer C, Trott KR, editors. Radiopathlogy of organs and Tissues. Berlin: Springer-Verlag; 1991. P. 191-212.
26. Winters BD, Saksida LM, Bussey TJ. Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval. Neurosci Biobehav Rev 2008; 32:1055-70.
27. Senanayake PD, Moriguchi A, Kumagai H, Ganten, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994; 15:919-26;
28. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of Angiotensin-(1-7) unmasked during combined treatment with linopril and losartan. Hypertension 1998; 31:669-705.
29. Allred A, Chappell MC, Ferrario CM, Diz DI. Differential actions of renal ischemic injury on the intrarenal Angiotensin system. Am J Physiol Renal Physiol 2000; 279:F636-45.
30. Ramanan S, Kooshki M, Zhao W, Hsu F-C, Riddle DR, Robbins ME. The PPARa agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation. Int J Radiat Oncol Biol Phys 2009; 75:870-7.
31. West MJ, Slomianka S, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionators. Anat Rec 1991; 231:482-97.
32. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96:857-81.
33. Gundersen HJG, Jensen EBV, Kieu K, Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J Microsc 1999; 193:199-211.
34. Slomianka L, West MJ. Estimators of the precision of stereological estimates: an example based on the CA1 pyrimidal cell layer of rats. Neuroscience 2005; 136:757-67.
35. Conner KR, Payne VS, Forbes ME, Robbins ME, Riddle DR. Effects of the AT1 receptor antagonist L-158,809 on microglia and neurogenesis after fractionated whole-brain irradiation. Radiat Res 2010; 173:49-61.
36. Ehninger D, Kempermann G. Neurogenesis in the adult hippocampus. Cell Tissue Res 2008; 331:243-50.
37. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharamcol 1995; 26:426-36.
38. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, et al. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 2008; 93:820-5.
39. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI. Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am J Physiol Heart Circ Physiol 2007; 293:H1327-33.
40. Moulder JF, Cohen EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007; 17:141-8.
41. von Bohlen und Halbach O, Albrecht A. The CNS reninangiotensin system. Cell Tissue Res 2006; 326:599-616.
42. Phillips MI, Menezes de Oliveira E. Brain renin angiotensin in disease. J Mol Med 2008; 86:715-22.
43. Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Exptl Neurol 2010; 223:326-33.
44. Kehoe AD, Nikiforov AM, Alexanin SS, Neronov EG, Tikhomirova OV, Shun'kov VB, et al. Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers. Eur J Neurol 2009; 16:95-100.
45. Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neurooncol 2007; 82:119-24.
46. Jenrow KA, Brown SL, Liu J, Kolozsvary A, Lapanowski K, Kim JH. Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus. Radiat Oncol 2010; 5:6.
47. Basso N, Paglia N, Stella I, de Cavanagh EMV, Ferder L, del Rosario Lores Arnaiz M et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Peptides 2005; 128:247-52.
48. Kerr DS, Bevilaqua LR, Bonini JS, Rossato JL, Kohler CA, Medina JH, et al. Angiotenisn II blocks memory consolidation through an AT2 receptor-dependent mechanism. Psychopharmacology 2005; 179:529-35.
49. Bonini JS, Bevilaqua IR, Zinn CG, Kerr DS, Medina JH, Izquierso I, et al. Angiotensin II disrupts inhibitory avoidance memory retrieval. Horm Behav 2006; 50:308-13.
50. Amenta F, Di Tullio MA, Tomassoni D. The cholinergic approach for the treatment of vascular dementia: evidence from preclinical and clinical studies. Clin Exp Hypertens 2002; 24:697-713.
51. Kehoe PG, Wilcock GK. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 2007; 6:373-8.
52. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009; 302:148-58.
53. Benicky J, Sanchez-lemus E, Honda M, Pang T, Orecna M, Wang J, Leng Y, Chiang D-M, Saavedra JM. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 2011; 36:857-70.
54. Miyoshi M, Miyano K, Moriyama N, Taniguchi M, Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipoploysaccharideinduced stimulation of rat microglial cells by suppressing nuclear factor jB and activator protein-1 activation. Eur J Neurosci 2008; 27:343-51.
55. Nakajima K, Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4:65-84.
56. Gendron L, Payet MD, Gallo-Payet N. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. J Mol Endocrinol 2003; 31:359-72.
57. Shi L, Adams MM, Long A, Carter CC, Bennett C, Sonntag WE. Spatial learning and memory deficits after whole-brain irradiation are associated with changes in NMDA receptor subunits in the hippocampus. Radiat Res 2006; 166:892-99.
58. Shi L, Olson J, D'Agostino R Jr, Linville C, Nicolle M, Robbins ME, et al. Aging masks detection of radiation-induced brain injury. Brain Res 2011; 1385:307-16.
59. Robbins M, Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys 2006; 64:6-12.
60. Varagic J, Trask AJ, Jessup JA, Chappell MC, Ferrario CM. New angiotensins. J Mol Med 2008; 86:663-71.
61. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-Angiotensin system: Angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 2004; 143:77-89.
62. Ratovich MJ, Grobe JL, Raizada MK. Angiotensin-(1-7) as an antihypertensive, antifibrotic target. Curr Hypertens Res 2008; 10:227-32.
63. Xu P, Sriramula S, Lazartiques E. ACE2/ANG-(1-7)Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol 2011; 300:R804-17.
64. Gilliam-Davis S, Gallagher PE, Payne V, Kasper SO, Tommasi EN, Westwood BN, et al. Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components. Physiol Genom 2011; 43:829-35.
65. Hellner K, Walthrt T, Schubert M, Albrecht D. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 2005; 29:427-35.
66. Asselbergs FW, van Gilst WH. Angiotensin converting enzyme inhibition in cardiovascular risk populations: a practical approach to identify the patient who will benefit most. Curr Opin Cardiol 2007; 22:267-72.
67. Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH. Differential effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res 2007; 168:440-5.
68. George AJ, Thomas WG, Hannan RD. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 2010; 10:745-59.